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Abstract
Thymic epithelial cells (TECs) are critical for the normal development and function of the thymus. Here, we examined the
developmental stages of TECs using quantitative assessment of the cortical and medullary markers Keratin 5 and Keratin 8
(K5 and K8) respectively, in normal and gain/loss of function mutant animals. Gain of function mice overexpressed RANKL in
T cells, whereas loss of function animals lacked expression of Traf6 in TECs (Traf6DTEC). Assessment of K5 and K8 expression
in conjunction with other TEC markers in wild type mice identified novel cortical and medullary TEC populations, expressing
different combinations of these markers. RANKL overexpression led to expansion of all medullary TECs (mTECs) and
enlargement of the thymic medulla. This in turn associated with a block in thymocyte development and loss of CD4+CD8+,
CD4+ and CD8+ thymocytes. In contrast, Traf6 deletion inhibited the production of most TEC populations including cortical
TECs (cTECs), defined by absence of UEA-1 binding and LY51 expression, but had no apparent effect on thymocyte
development. These results reveal a large degree of heterogeneity within the TEC compartment and the existence of several
populations exhibiting concomitant expression of cortical, medullary and epithelial markers and whose production is
regulated by RANKL and Traf6.
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Introduction
Normal development of T cells in the thymus depends on
interactions between the T cell receptors (TCRs) of developing
thymocytes and peptide antigens presented by cortical and
medullary thymic epithelial cells (cTECs and mTECs respective-
ly). Self-antigen presentation on cTECs regulates thymocyte
positive selection, while self-antigens expressed on mTECs
mediate negative selection of autoreactive T cells [1]. Over the
past several years mTECs have emerged as important regulators of
T cell tolerance by ectopically expressing a wide range of tissue-
specific antigens (TSAs) [2]. T cells expressing TCRs that exhibit
high affinity for TSAs are eliminated in the thymus through
negative selection, whereas TCRs that bind to TSAs with
intermediate affinity are diverted into the regulatory T cell (Treg)
pool [3,4,5,6,7].
The transcriptional regulator Aire controls the expression of a
large fraction of TSAs in mTECs [8]. Mutations in the aire gene in
humans result in the development of autoimmune polyendocrino-
pathy-candidiasis-ectodermal dystrophy (APECED) syndrome
[9,10,11], whereas Aire deletion in mice leads to autoantibody
production against and inflammatory infiltrates in multiple tissues
[8]. In addition to Aire, genetic mutations that affect the
development of mTECs have varied effects on mTEC function
and autoimmunity. Deletion or mutation of RelB [12], the tumor
necrosis factor receptor-associated factor 6 (Traf6) [13], NFkB-
inducing kinase (NIK) [14] and the lymphotoxin b receptor
(LTbR) [15], leads to defective development of mTECs, reduced
or absent medulla and development of autoimmunity [16,17]. In
addition, the receptor activator of NFkB ligand (RANKL) and
CD40 ligand (CD40L) expressed on CD4+ T cells together with
their respective receptors RANK and CD40 expressed on mTECs,
were recently shown to regulate development and maintenance of
mature mTECs [18,19]. RANKL and CD40L are selectively
upregulated in CD4+ T cells and positively selected CD4+
thymocytes expressing RANKL are necessary for mTEC cellular-
ity illustrating the role of thymocyte-TEC crosstalk in normal T
cell development [17,20].
Although the development of thymic epithelial cells is not well
understood, cTECs and mTECs are thought to arise from a
common embryonic progenitor that gives rise to both lineages
[21]. In the adult thymus, LY51 and CD205 expression identifies
cTECs, while mTECs are LY512CD2052 and bind the plant
lectin ulex europeus agglutinin-1 (UEA-1). mTECs are further
subdivided into three cell subsets expressing different levels of
CD80/86, MHCII and Aire [2,17]. In addition, mTECs express
the epithelial cell marker Keratin 5 (K5) whereas cTECs express
Keratin 8 (K8). Although K8 and K5 are considered medullary
and cortical specific markers, we and others observed heteroge-
neous expression of both proteins within the thymic medulla,
suggesting the existence of TEC populations coexpressing different
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levels of these proteins [4,22,23,24]. Therefore, we performed
quantitative analysis of keratin and other TEC marker expression
and used gain and loss of function RANKL and Traf6 mutant
mice respectively, to identify additional TEC subsets whose
development was regulated by these proteins.
Materials and Methods
Animals
Transgenic mouse lines in the C57BL/6 background overex-
pressing RANKL under the control of the murine CD4 enhancer/
promoter lacking the CD4 silencer [25] were described previously
[26]. Traf6DTEC mice were generated by crossing floxed Traf6
mice [27] to animals in which a cDNA encoding for the Cre
recombinase was knocked into the 39 untranslated region (39UTR)
of the foxn1 locus [28,29]. Traf6fl/fl/foxn1-Cre (Traf6DTEC) mice
were backcrossed for 8 generations to the C57BL/6 background.
C57BL/6 mice were purchased from Jackson Laboratory (Bar
Harbor, ME). Animals were housed in specific pathogen-free
conditions and were used and maintained in accordance with
institutional guidelines. All efforts were made to minimize
suffering. Animal protocols were approved by the Institutional
Animal Care and Use Committee of the Icahn School of Medicine
at Mount Sinai (Protocol # 09-00102).
Thymic Epithelial Cell (TEC) Isolation
Individual thymi from different animals were dispersed and
single cell suspensions enriched using a percoll gradient as
described previously [30,31]. Briefly, thymi from mice between
7–9 weeks of age were minced into small pieces and enzymatically
digested in RPMI1640 containing 0.2 mg/ml Collagenase D
(Roche), 6.5 U/ml Dispase I (Roche) and 301 U/ml Dnase I
(Invitrogen) at 37uC for 30 min. Upon completion of the digestion,
0.5M EDTA (1:50 v/v, Invitrogen) was added to the cell
suspensions for 5 min and after washing, cells were loaded on a
1.115 g/ml and 1.065 g/ml Percoll (Sigma) density gradient
topped off with 1X phosphate buffered saline (PBS). The Percoll/
PBS gradient was centrifuged at 2700 rpm for 30 min at 4uC and
cell aggregates formed between the PBS and 1.065 g/ml Percoll
layer were collected for analysis by flow cytometry.
Flow Cytometry
Percoll gradient purified TEC suspensions were incubated with
anti-CD16/CD32 Fc block (2.4G2, BD Biosciences, 1:10 dilution)
to block Fc receptors along with biotinylated UEA-1 (1:25, Vector
Laboratory) for 25 min at room temperature (RT). Next, the cells
were incubated with PerCP-conjugated Streptavidin (1:50, BD
biosciences), anti-MHCII-eFluor450 (1:50, M5/114.15.2,
eBioscience) and 2CD45-PE (1:500, 30-F11, eBioscience) for
25 min at RT. When relevant, anti-EPCAM1-PE-Cy7 (1:100,
G8.8, eBioscience) was added along with the above mentioned
antibodies. Affinipure anti-rat Fab fragment (1:10, Jackson
Immunoresearch) was added for 35 min followed by fixation by
cytofix/cytoperm solution (BD Biosciences) for 20 min. Fixed cells
stained with extracellular markers were resuspended in Perm/
Wash buffer (BD Biosciences) overnight, followed by incubation
with anti-K8 (TROMA-I clone; DSHB, University of Iowa) and -
K5 (AF138 clone; Covance) antibodies 1:50 dilution for 60 min at
RT followed by Perm/Wash buffer wash. The cells were stained
with APC-conjugated goat anti-rat IgG (1:50, Jackson Immunor-
esearch) and FITC-conjugated goat anti-rabbit IgG (1:50, Jackson
Immunoresearch) for K8 and K5 respectively. Samples were
analyzed on an LSRII (BD Bioscience) flow cytometer at the
Mount Sinai Flow Cytometer Core Facility and the raw data
analyzed with FlowJo software (Treestar). Cells stained with Pacific
Blue Rat IgG2b (1:50, RTK4530, Biolegend), PE-Cy7 Rat IgG2a
(1:100, eBR2a, eBioscience), Streptavidin-PerCP, APC-goat anti-
rat IgG and FITC-goat anti-rabbit IgG were used as isotype
controls.
For experiments staining for Aire expression, Percoll-gradient-
purified TECs were incubated in anti-CD16/CD32 Fc Block and
biotylated UEA-1 for 25 min followed by Streptavidin conjugated
PerCP, anti-MHCII-eFluor450 and 2CD45-PE at the dilutions
described above for 25 min followed by fixation/permeabilization
solution (eBioscience) for 1 hour. Fixed cells stained with
extracellular markers were incubated with anti-Aire-AlexaFluor
647 antibody (1:100, 5H12, eBioscience) for 1 hour. For
experiments staining for cortical marker expression, Percoll-
gradient-purified TECs were incubated in anti-CD16/CD32 Fc
Block and biotylated UEA-1 for 25 min followed by Streptavidin
conjugated PerCP, anti-MHCII-eFluor450, 2CD45-PE, -LY51-
AlexaFluor 647 (1:200, 6C3, Biolegend) and -EpCAM1-FITC
(1:100, G8.8, eBioscience) for 25 min. Cells were analyzed by flow
cytometry as described above.
In Vitro Cultures of Sorted TECs
Thymi from 3-week old mice were isolated and pooled TEC
suspensions were purified as described above. Percoll gradient
purified TEC suspensions were incubated with anti-CD16/CD32
Fc block and biotinylated UEA-1 for 25 min at RT followed by
incubation with PerCP-conjugated Streptavidin, anti-MHCII-
eFluor450 and 2CD45-PE for 25 min at RT. UEA-12MHCII2
and UEA-1loMHCII2 cell populations were sorted on a BD Influx
sorter. Sorted cells were incubated for three days in 96 well plates
in DMEM supplemented with 4.5 g/L glucose and L-glutamine
and 10% FCS in the presence or absence of stimulating anti-
RANK antibody (AF692, R&D Systems, 10 mg/mL) as described
[32]. At the end of the incubation, cells were stained with anti-
MHCII-eFluor450, 2EPCAM-1-PE-Cy7 and -CD45-PE. Stained
cells were analyzed by flow cytometry.
Immunohistochemistry
Frozen thymic sections (7 mm) from adult mice (6–9 weeks old)
were fixed with ice cold acetone, permeabilized with RPMI 1640
(Gibco) containing saponin (0.05% w/v, Sigma), glycine (10 mM,
Fisher Scientific) and Donkey Serum (5% v/v, Sigma) and blocked
with egg white (10% v/v) and BSA (0.05% w/v, Sigma). PBST [1x
PBS with Tween 20 (0.05% v/v, Fisher Scientific)] was used as
wash buffer. The sections were then incubated with anti-K8
(TROMA-I clone; DSHB, University of Iowa) and anti-K5
antibodies (AF138 clone; Covance) at 1:300 and 1:1000 dilution
respectively for 1 hour at RT followed by incubation with Alexa
Fluor 488 anti-rat IgG (1:200, Invitrogen) and Cy-5 anti-rabbit
IgG (1:200, Invitrogen) secondary antibodies for visualizing K8
and K5 respectively. The sections were also stained with 2 mg/ml
rhodamine conjugated UEA-1 (1:100, Vector Laboratories) for 1
hour at RT. After overnight incubation with biotin-conjugated
MHCII (ER-TR3, Abcam) at 1:100 dilution, Streptavidin-Alex
Fluor 350 (1:100, Invitrogen) was added for an hour. Images of
stained tissues were acquired with an Axioplan 2IE fluorescence
microscope (Carl Zeiss) at the Mount Sinai Microscopy core
facility.
Lymphocyte Purification and Analysis
Cell suspensions of crushed thymi from wild type and RANKL-
Tg mice, were passed through 40 mm cell strainer and suspended
in PBS. 26106 cells were stained with anti-CD45-AlexaFluor780
(30F11, eBioscience), 2CD4-PE-Cy7 (GK1.5, eBiosciences),
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2CD8-eFluor450 (53–6.7, eBioscience), 2CD44-PE (IM7, BD
biosciences) and 2CD25-APC-Cy7 (PC61, BD biosciences)
antibodies and analyzed by flow cytometry.
Statistical Analysis
Statistical significance was assessed using the two-tailed
Student’s t-test using Microsoft Excel2010 software. P values less
than 0.05 were considered significant. *p,0.05; **p,0.01:
***p,0.001.
Results
The Thymic Medulla Consists of Heterogeneous TEC
Subsets
Thymic sections of wild type mice were stained with anti-K8, -
K5, -MHCII antibodies and UEA-1. While K5 expression was
largely confined in the medulla (Figure 1A, top two panels) K8 was
present in both the medulla and cortex (Figure 1A, top and third
panels). In addition, whereas most K5+ cells also coexpressed K8
(Figure 1A, top three panels), some cells in the medulla were
positive for only K8 (Figure 1A, top and third panels, dashed
arrows). Three populations of mTECs have been defined based on
the expression of MHCII, CD80/86, Aire and UEA-1 binding:
immature, intermediate and mature [2,17] (Figure 1B). Immature
mTECs express/bind low levels of MHCII/CD80/86 and UEA-1
respectively (TEClow), whereas intermediate and mature mTECs
express high levels of MHCII/CD80/86, bind high levels of UEA-
1 (TEChi) and are Aire2 or Aire+ respectively (Figure 1B)
[2,17,33]. TEClow and TEChi cells were indeed present in the
medulla of wild type mice as staining thymic sections with anti-
MHCII antibody and UEA-1 revealed cell populations binding
low and high levels of these markers (Figure 1A, bottom two
panels). Among the K5+K8+ medullary cells, we identified three
distinct populations based on MHCII coexpression and UEA-1
binding: K8+K5+UEA-1+MHCII+ (Figure 1A, closed arrows);
K8+K5+UEA-1+MHCII2 (Figure 1A, open arrow); and
K8+K5+UEA-1-MHCII2 cells (Figure 1A, arrowheads). There-
fore, the heterogeneous staining of K8, K5, MHCII and UEA-1
suggested the existence of several distinct cell subsets within the
medullary compartment.
Quantitative Assessment of Cortical and Medullary
Marker Expression Identifies Novel TEC Subsets
To further characterize the thymic TEC compartment, we
developed a multi-color flow cytometry protocol that allowed
simultaneous quantitative analysis of K8, K5, MHCII and UEA-1
expression/binding in TEC subsets. Analysis of TEC suspensions
from wild type mice revealed several distinct epithelial (CD452)
populations expressing different levels of these markers on UEA/
MHCII and K8/K5 dot plots (Figure 1C). The gating strategy for
deducing the different populations was determined based on
isotype control staining (Figure 1D), marker expression levels and
by overlaying subpopulations gated on UEA/MHCII onto K8/
K5 dot plots and vise-versa (presented in Figure 2 below). In
addition to the known populations pointed by arrows in Figure 1B
and C (left panel, solid squares), four other populations were
discernible within the UEA/MHCII dot plots of CD452 cells
enclosed in dotted squares: UEA-1lowMHCII2; UEA-1high-
MHCIIlow; UEA-12MHCIIlow; and UEA-12MHCIIhi
(Figure 1C, left panel, gates 2, 4, 6 and 7 respectively). Similarly,
six different cell populations expressing variable levels of K8 and
K5 were gated on a K8/K5 dot plot based on the same strategy as
with the UEA/MHCII plots. The total numbers of the different
populations within the UEA/MHCII (gates 1–7) and K8/K5
(gates 1–6) dot plots from several wild type mice were quantified
by flow cytometry (Figure 1E).
To further characterize these TEC subpopulations, cells gated
on UEA/MHCII dot plots (Figure 1C, left panel) were overlaid
onto K8/K5 dot plots (Figure 2A, blue dots) and K8/K5-gated
subpopulations (Figure 1C, right panel) overlaid onto UEA/
MHCII dot plots (Figure 2B, red dots). Gates 1 of the UEA/
MHCII and K8/K5 dot plots (Figure 1C) contained cells that did
not express any of the markers tested (Figure 2A and B, panels a,
populations 1) and were designated K82K52UEA-12MHCII2
(Figure 2C, table). The UEA/MHCII gate 1 also contained cells
that expressed low levels of K5 and were identical to cells present
in gate 2 of K8/K5 dot plots (Figure 2A panel a, and 2B panel b,
populations 1A and 2A). These cells were designated K82K5lo-
wUEA-12MHCII2 TECs (Figure 2C, table). UEA-1 binding was
first detected in cells contained within gates 2 of UEA/MHCII
and K8/K5 dot plots (Figure 2A and B, b panels, populations 2)
and these were designated K82K5lowUEA-1lowMHCII2 TECs
(Figure 2C, table). In addition, the UEA/MHCII dot plot gate 2
contained another cell subset in which K8 expression first became
discernible (Figure 2A, panel b, population 2A). This cell subset
overlapped with a population within gate 3 of K8/K5 dot plots
(Figure 2B, panel c, population 3A) and was designated K8low-
K5lowUEA-1lowMHCII2 (Figure 2C). Gate 3 on the UEA/
MHCII dot plots (Figure 1C, left panel) contained cells that
coincided with the previously defined TEClow subset [34], in
which MHCII upregulation first became evident (Figure 2A and
B, c panels, populations 3) and was designated K8lowK5lowUEA-
1lowMHCIIlow TECs (Figure 2C). Further increases in K8 and K5
expression correlated with MHCII upregulation and UEA-1
binding in populations 4 and 5 (Figure 2A and B, panels d and
e respectively) designated K8intK5hiUEA-1hiMHCIIlow and K8hi-
K5intUEA-1hiMHCIIhi (Figure 2C), the latter representing the
previously described (TEChi) mature TEC cell subset (Figure 1B)
[33].
In addition to the UEA-1+ cell populations mentioned above,
we also identified UEA-12 cells in our TEC cell preparations that
expressed low and high levels of MHCII (Figure 1C, left panel,
populations 6 and 7). Overlaying UEA/MHCII gates 6 and 7 onto
K8/K5 dot plots showed that these cells expressed low levels of
K5, K8 and MHCII (Figure 2A and B, f panels, populations 6)
designated as K8lowK5lowUEA-12MHCIIlow (Figure 2C, table).
This population was also contained in gate 3 of K8/K5 dot plots
and overlapped with the 3 and 3A cell subsets (Figure 2B, compare
identical panels c and f). Cells in gate 7 of UEA-1/MHCII dot
plots expressed intermediate and high levels of K8 and MHCII
respectively (Figure 2A and B, panels g populations 7) and were
designated as K8intK5lowUEA-12MHCIIhi (Figure 2C, table).
The cell subsets identified in the overlays above were color
coded and renamed as populations 1–9 (P1–P9) (Figure 2C, table).
The overlapping subpopulations within gates 1 and 2 in the UEA/
MHCII dot plots and gates 2 and 3 in the K8/K5 dot plots are
shown schematically in Figure 2C (dot plots) and the percentages
and total numbers of the overlaid populations determined by flow
cytometry are shown in Figure 2D. Because the overlaid
populations in Figure 2A and B did not account for all the cells
gated in the UEA/MHCII and K8/K5 dot plots shown in
Figure 2C (dot plots), the proportion of cells expressing all four
markers (Figure 2E, colored bars) was determined in relation to
the total populations gated (Figure 2E, gray bars). Although the
identity of the cells represented in the gray bars is unknown, these
could be other TEC subsets expressing variable combinations of
the markers tested. Consistent with this, both K8+K5+UEA-
1+MCHII+ and K8+K5+UEA-12MCHII2 cells were present in
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the thymic medulla of wild type animals (Figure 1A, arrows and
arrowheads respectively). However, the opposite was not true as
we were not able to detect K82K52UEA-1+MHCII+ cells in any
of the thymic sections examined. Together, these results revealed
the existence of several TEC subpopulations coexpressing variable
levels of the different markers tested, suggesting a greater
complexity of the TEC compartment than previously thought.
Further Characterization of the Identified TEC Subsets
Using Epithelial and Cortical Marker Expression
In addition to MHCII, K8, K5 and UEA-1, known TEC
subsets also express the pan-epithelial cell marker EpCAM1 [17].
Additionally, LY51 expression has been used to distinguish cTECs
from mTECs, where LY51hiEpCAM1+ cells have been shown to
represent cTECs and LY512/lowEpCAM1+ cells have been
described as mTECs [17,31]. EpCAM1 expression on the different
cell subsets was analyzed in conjunction to the other markers by
overlaying CD45–gated EpCAM1+ TECs (Figure 3A) onto UEA/
MHCII or K8/K5 dot plots as described in Figure 2 and as shown
(Figure 3B). Consistent with the results presented in Figure 2C,
histogram analysis of individual TEC markers revealed that
upregulation of K5 followed by increased UEA-1 binding were the
first markers to be detected on TEC subsets (Figure 3C,
populations P2 and P3 respectively). EpCAM1+ cells were also
detected in the P3 and more so in the P4–P5 populations
(Figure 3C), whereas almost all cells in the P6 and P7
subpopulations expressed high levels of EpCAM1+ which coin-
cided with increased UEA-1 binding and in the case of P7, MHCII
expression (Figure 3C and D and Figure S1B–F). The total
numbers and frequency of EpCAM1+ cells in the different
populations contained within the total cells gated were determined
by flow cytometry (Figure 3D and Figure S1A). The expression
levels of EpCAM1 and the other markers examined were
confirmed by mean fluorescence intensity (MFI) (Figure S1B–F)
and the designations of the different TEC populations deduced
from overlays, histograms and MFI values are summarized in
Figure 3E. Based on UEA-1binding and K5 expression we believe
that the P3–P7 cell subsets represent mTECs where the P2 subset
expressing low levels of K5 may be representative of an early stage
along the mTEC lineage differentiation.
In contrast to the P3–P7 cells subsets we defined, the P8 and P9
subpopulations did not bind UEA-1 despite expressing different
levels of K5, K8, MHCII and EpCAM1 (Figure 3C and Figure
S1B–F), suggesting that these cells may represent cTECs. K8+K5+
double positive cells that were MHCII+UEA-12 were previously
observed at the corticomedullary junction (CMJ) of the thymus
and were described as minor cortical cells proposed to serve as
precursors to both cTECs and mTECs [24]. To further
characterize these populations we stained thymic TEC cell
suspensions with LY51 and EpCAM1. At least three different
populations were discernible expressing high and low levels of
these markers determined from LY51/EpCAM1 dot plots and
MFI values (Figure S2A and B) and as described [31]. Overlaying
LY51hi cTECs (Figure S2A, gate 1) onto UEA-1/MHCII dot plots
overlapped with gate 7 containing the P9 subset (defined in
Figure 3B), although LY51hi cells that bound low levels of UEA-1
were also present (Figure S2B, left panel and histogram). LY512/
low EpCAMhi mTECs (Figure S2A, gate 2) overlapped with gates 4
and 5 (Figure S2B middle panel) containing populations P6 and P7
(defined in Figure 3B), whereas LY51lowEpCAM1low cells were
distributed between gates 1, 2, 3 and 6 on UEA-1/MHCII dot
plots (Figure S2B, right panel) containing the P1–5 and P8 cell
subsets (defined in Figure 3). Although cells within gates 6 and 7
containing the P8 and P9 cell subsets respectively lacked the ability
to bind UEA-1, they differed in their LY51 expression levels
(Figure S2C, histogram). Therefore, while P9 consists at least
partially of cTECs, P8 cells appear to represent a distinct TEC
population. As these cells express low levels of both K5 and K8 but
not UEA-1 (Figure S1C–E) and K8+K5+UEA-12 cells have been
proposed to act as mTEC and cTEC precursors [24], it is possible
that the P8 population contains these precursors. The designations
for LY51 expression on the different subsets are shown in
Figure 3E.
Aire expression and TSA induction have been shown to occur
in the most mature UEA-1hiMHCIIhi mTECs [17,33]. As a proof
of principle and to determine which of the different subsets we
identified contained Aire+ cells, in parallel experiments we also
examined Aire expression in the different mTEC subpopulations
we defined above (P2–P7). Because of limited availability of
antibody clones and fluorescent conjugates, we were unable to
simultaneously assess Aire expression with all of the other markers.
Therefore, the percentages and total numbers of Aire+ cells were
determined in UEA-1/MHCII dot plots. Overlay of Aire-
expressing cells within the CD452 gate onto UEA-1/MHCII
dot plots, (Figure 4A, red dots), revealed that the majority of Aire+
cells were contained within gate 5 Figure 4A and B) corresponding
to the P7 cell subset defined in Figure 3. A minority of Aire+ cells
was also present in gate 4 of the same dot plots corresponding to
the P6 population of mTECs (Figure 4A and B). Quantification by
flow cytometry of the percentages and total numbers of Aire+
mTECs within the different populations gated on UEA/MHCII
dot plots are shown in Figure 4C. As not all cells in the P7 subset
expressed Aire (Figure 4C, bottom bar graph), these results were
consistent with previous evidence showing that the most mature
TEChi cell subset consists of both Aire2 and Aire+ mTECs
[17,33]. Because cells in the P7 cell subset contained within gate 5
(Figure 4A, right panel, red dots) also express intermediate and
high levels of K8 and K5 as well as EpCAM1 (Figure 2A, d and e
panels and Figure 3C), we believe that these cells can be
designated as K8hiK5intUEA-1hiMHCIIhiAire+EpCAM1hi repre-
senting the previously described TEChi Aire+ mature mTECs. The
phenotypes of the cell subsets we characterized with respect to K8,
K5, MHCII, Aire and EpCAM1 expression and UEA-1 binding,
are summarized in Figure 3E. Together, these results suggest that
K8 expression is not solely confined in the thymic cortex but
rather coexpression of cortical, medullary and epithelial markers is
dynamically regulated in different TEC subsets in the thymic
medulla.
Figure 1. The thymic medulla contains several distinct TEC populations. (A) Frozen thymic sections from ,8-week-old mice were stained
with K5, K8, MHCII and UEA-1. Arrows point to different TEC subsets as described in the text. Scale bar = 50 mm. (B) Schematic representation of
known subsets of mTECs defined by expression/binding levels of MHCII, Aire and UEA-1. (C) Purified thymic epithelial cells from ,8-week-old mice
were stained with anti-CD45, -MHCII, -K5 and -K8 antibodies and biotinylated UEA-1, and analyzed by flow cytometry. Seven populations based on
UEA-1 binding and MHCII expression (left dot plot) and six populations based on K5 and K8 expression levels were identified (right dot plot). (D)
Isotype controls for UEA, MHCII, K8 and K5 were included in the experiment as shown. (E) The total numbers of the populations within the different
gates of UEA/MHCII (1–7) and K8/K5 (1–6) dot plots were quantified by flow cytometry. Bar graphs represent the mean+Standard Error of the Mean
(SEM). n = 12, results in C–E were pooled from at least three independent experiments.
doi:10.1371/journal.pone.0086129.g001
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Figure 2. Identification of novel TEC populations by simultaneous expression of cortical and medullary TEC markers. (A and B) The
different cell populations subgated on UEA/MHCII and K8/K5 dot plots from Figure 1C were overlaid onto K5/K8 (A) and UEA/MHCII (B) dot plots
respectively (panels a–g) to identify cells coexpressing these markers. Panel f in B is a replica of c to show the overlapping populations within gate 3
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RANKL and Traf6 Regulate the Expansion of the
Identified EpCAM1+ TEC Subsets
As RANKL and Traf6 have been shown to regulate TEC
differentiation [19,35], we used gain and loss of function mutations
for these proteins to examine their impact on the populations we
identified. RANKL transgenic (RANKL-Tg) mice overexpressing
membrane-bound RANKL in T cells and Traf6DTEC conditional
knockout mice were generated as described in Materials and
Methods. Transgenic RANKL expression was detected on
CD4+CD8+ double positive (DP), and CD4+ and CD8+ single
positive (SP) thymocytes by flow cytometry (data not shown).
Hematoxilin and eosin (H&E)-stained cross-sections of thymic
lobes from ,12-week old wild type and RANKL-Tg mice
revealed a marked expansion of the thymic medulla in RANKL-
Tg animals which associated with greatly reduced or absent cortex
(Figure 5A, left and middle panels). In contrast, deletion of Traf6
in TECs resulted in a diminished medullary area (Figure 5A, right
panel), consistent with previously published results with straight
Traf6 knockout and conditional Traf6DTEC mice [13,29].
UEA/MHCIIRK8/K5 and K8/K5RUEA/MHCII overlays
performed as in Figure 2A and B, revealed several qualitative and
quantitative differences in TEC subsets between wild type and
RANKL-Tg or Traf6DTEC mice (Figure 5B and C). Overex-
pression of RANKL skewed TEC populations towards the P6 and
P7 mTEC subsets in terms of UEA-1 and MHCII expression
compared to wild type controls (Figure 5C middle panels and D).
The P6 and P7 cell subsets in the UEA/MHCIIRK8/K5 overlay
of TECs from RANKL-Tg mice exhibited a downward shift in K5
expression levels compared to wild type controls, which correlated
with a concomitant increase in immature populations expressing
lower levels of K5 (Figure 5B, compare top and middle d and e
panels). The P6 and P7 cell subsets bound and expressed similar
levels of UEA-1 but there was an increase in cells expressing lower
levels of MHCII within the P6 population on the K8/K5RUEA/
MHCII overlay of RANKL-Tg mice (Figure 5C, compare top and
middle d and e panels). Despite the differences in expression levels
of K5 and MHCII in the P6 and P7 cell subpopulations, RANKL
expression led to the expansion of most of the P1–P7 cell subsets
suggesting that these cells indeed represent mTECs (Figure 5D).
This was also consistent with the ability of these cells to bind UEA-
1 and with the role of RANKL in mTEC regulation. In contrast,
the P8 and P9 populations were reduced or absent from the UEA-
1/MHCIIRK8/K5 and K8/K5RUEA/MHCII overlays of
RANKL-Tg TECs compared to controls (Figure 5B and C,
compare top and middle f and g panels, and Figure 5D). The
decrease in populations P8 and P9 coincided with the depletion of
the cortex in the RANKL-Tg thymi (Figure 5A) which together
with their inability to bind UEA-1 is consistent with the idea that
these cells comprise minor cTECs. The cells represented by red
dots in the same RANKL-Tg dot plots (Figure 5C, middle f and g
panels) likely represent mature mTECs expressing lower levels of
K5 (shown in Figure 5B, top an middle d and e panels). In
contrast to RANKL overexpression, Traf6 deletion in TECs
resulted in severe depletion of the P6 and P7 subsets evident in
both the UEA/MHCIIRK8/K5 and K8/K5RUEA/MHCII
overlays compared to controls (Figure 5B and C, top and bottom d
and e panels and 5E). Deletion of Traf6 had a less potent effect on
the P2–P5 populations as these cell subsets were still present in the
overlays (Figure 5B and C top and bottom a–c panels) and their
total numbers were similar to or reduced as compared to controls
(Figure 5E). The P8 and P9 populations were also reduced or
depleted by Traf6 deletion compared to controls, suggesting that
in addition to mTECs Traf6 also regulates the production of
minor cortical cells (Figure 5B and C, top and bottom f and g
panels, and 5E).
CD452EpCAM1+ cells in the different cell subsets from wild
type and RANKL-Tg or Traf6DTEC mice were also analyzed on
EpCAM1RUEA/MHCII and EpCAM1RK8/K5 overlays as
described in Figure 3 above and as shown (Figure 6A and B, blue
dots). RANKL overexpression caused significant increases in all
except the P8 and P9 EpCAM1+ cell subsets which were
significantly reduced in RANKL-Tg mice. There was a large
increase in the EpCAM1+ cell numbers in the P5 cell subset which
showed a 6- and 8-fold increase in wild type and RANKL-Tg mice
respectively compared to the P4 subpopulation (Figure 6C). These
results were consistent with previous evidence showing that
TEClow mTECs (corresponding to our P5 cell subset) are
comprised of immature proliferating cells [17,33]. Despite the
expansion of the P5 cell subset, cells within this population
expressed low levels of EpCAM1 in both wild type and RAKL-Tg
mice (Figure S1B and 6E, MFI values), while EpCAM1 levels
increased in the P6 and P7 cell subsets without further expansion
of these cells (Figure 6C and E and S1B). These results suggest that
the P4 and P5 subpopulations may represent a transitional
checkpoint in TEC differentiation that involves expansion of cells
expressing low levels of EpCAM1 followed by EpCAM1
upregulation without further expansion in the P6 and P7 subsets.
In contrast to RANKL-Tg mice, EpCAM1+ cell subpopulations
isolated from Traf6DTEC animals were significantly decreased
compared to controls with the most dramatic inhibition evident in
the P5 and especially the P6 and P7 cell subsets (Figure 6D), which
contrasted with RANKL-mediated expansion of these populations
(compare Figure 6C and D). Both RANKL overexpression and
Traf6 deletion induced significant changes in the P1 cell which
could be due to the existence of rare EpCAM1+ cells within this
population. EpCAM1+ cells within the P8 and P9 subsets were
decreased by both RANKL overexpression and Traf6 deletion
(Figure 6C and D), which in the case of RANKL-Tg mice was
consistent with the absence of a cortical region in their thymus
(Figure 5A, middle panel). Together, the results described above
suggest that the TEC compartment exhibits a complex differen-
tiation program involving several subpopulations whose expansion
and marker upregulation in controlled by RANKL and Traf6.
Temporal Regulation of TEC Subset Expansion in the
Postnatal Thymus
Given the different levels of EpCAM1 and MHCII on the
different TEC subsets and to explore a possible precursor role for
the P1–P4 populations expressing no or low levels of MHCII and
EpCAM1 respectively, we sorted cells within gates 1 and 2 on
UEA-1/MHCII dot plots containing these populations (Figure 2C
dot plots) and as shown in Figure S3A and incubated sorted cells
with a stimulating anti-RANK antibody in vitro (Figure S3). The
rational for these experiments was to examine whether RANK-
of the K8/K5 dot plots. (C) Color-coded cell subsets defined in the UEA/MHCII and K8/K5 overlays in A and B were renamed and designated as
described in the text and as shown (table). The dot plots show a schematic representation of the overlapping populations defined in A and B. (D)
Percentages and total numbers of each cell subset were quantified by flow cytometry. (E) Bar graphs show the proportion of each cell subset
characterized in C (color bars) within the total population of cells gated (gray bars). Bar graphs represent mean+SEM. n = 12 data were pooled from at
least three independent experiments.
doi:10.1371/journal.pone.0086129.g002
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Figure 3. Rare EpCAM1+ cells are present in the different TEC cell subsets. (A and B) EpCAM1+ cells gated on CD452 epithelial cells were
overlaid on UEA/MHCII and K8/K5 dot plots (blue dots). (C) EpCAM1 and other marker expression levels for each cell subset were analyzed by flow
cytometry on histograms. An isotype control was used to differentiate EpCAM1+ from EpCAM12 cells. (D) Total numbers of all CD452 cells gated as
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mediated stimulation of sorted populations was able to give rise to
MHCII+ cells in vitro which would then suggest that the sorted
populations contained precursors to more mature mTECs.
Staining cultured cells with EpCAM1 and MHCII revealed that
the percentages of EpCAM1+ TECs in anti-RANK-stimulated
cultures were significantly increased compared to untreated cells
(Figure S3B). This was accompanied by a modest increase in the
levels of EpCAM1 (Figure S3C, left histogram) mirroring the
results we obtained with RANKL-Tg mice (Figure 6C and E)
however, these in vitro cultures failed to yield MHCII+ TECs
(Figure S3C, right histogram). These results suggest that although
the P1–P4 cell subsets contain cells that respond to RANK
stimulation, upregulate EpCAM1, and may act as precursors of
more mature TECs additional events are required for upregula-
tion of MHCII and TEC maturation. This would then be
consistent with the existence of a checkpoint between populations
P4 and P5 mentioned above regulating a transitional expansion
and/or survival of cells within the P5 cell subset.
To gain additional insight into the role of the subsets we
identified in TEC development, we analyzed TEC cell suspensions
in 1- and 6-week-old wild type and RANKL-Tg mice. We chose
these time points because we and others have shown that small
well as EpCAM1+ cells within the different gates were determined by flow cytometry. (E) Nomenclature assignments of the TEC subsets identified. Bar
graphs represent the mean+SEM. n = 16, results were pooled from at least three independent experiments.
doi:10.1371/journal.pone.0086129.g003
Figure 4. Aire expression is upregulated in the mature TEChi cell subset. (A) Aire-expressing cells within the CD452 gate were overlaid onto
UEA-1/MHCII dot plots of TEC suspensions (right panel, red dots). (B) Aire expression levels within each cell population gated on the UEA/MHCII dot
plot in 4A were analyzed by flow cytometry on histograms. (C) The percentages and total numbers of Aire+ cells within the different UEA-1/MHCII-
gated populations (1–7) were determined by flow cytometry. Bar graphs represent mean+SEM with n= 10 from 3 different experiments. (D) Table
shows the name designations of the different subsets based on expression levels of all markers tested.
doi:10.1371/journal.pone.0086129.g004
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Figure 5. RANKL and Traf6 regulate the expansion of TEC subsets. (A) Mosaic images of H&E sections of thymic lobes from ,3-month-old
RANKL-Tg and Traf6DTEC mice show the effect of RANKL expression and Traf6 deletion on medullary architecture. Scale bars = 500 mm. (B and C)
UEA/MHCIIRK8/K5 (blue dots) and K8/K5RUEA/MHCII (red dots) overlays generated as in Figure 2A and B comparing patterns of UEA-1, MHCII, K8
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medullary islets in newborn mice expand and fuse to form a
cohesive medulla within a week after birth and which reaches is
normal size by six weeks of age [31,36,37]. Based on the perinatal
expansion of the medulla, we reasoned that there should be more
precursor cells to facilitate medullary formation and production of
mature mTECs. UEA-1/MHCIIRK8K5 and K8/K5RUEA-1/
MHCII overlays revealed significant increases in the P2 and P3
cell subsets in 1-week-old compared to 6-week-old wild type mice
whereas the P5 subset was enriched in 6-week old animals
consistent with the results shown above in Figure 5D (Figure 7A
and K5 expression in wild type, RANKL-Tg and Traf6DTEC mice. (D and E) Quantification of the total numbers of TEC subpopulations in wild type and
RANKL-Tg (D) or Traf6DTEC (cKO) mice (E) within the total gated populations as shown in Figure 1C. Bar graphs represent mean+SEM. At least 9 mice
were used per genotype from four independent experiments.
doi:10.1371/journal.pone.0086129.g005
Figure 6. RANKL overexpression and Traf6 deletion regulate the expansion of EpCAM1+ TECs. (A and B) CD45–gated EpCAM1+ cells
from ,8-week-old mice were overlaid onto UEA/MHCII and K8/K5 dot plots as in Figure 3 and as shown (blue dots). (C and D) The total numbers of
EpCAM1+ TECs in the different subsets gated on UEA/MHCII and K8/K5 dot plots (circles in A and B) from wild type, RANKL-Tg and Traf6DTEC mice
were analyzed by flow cytometry. Bar graphs represent the mean+SEM. Results were pooled from four independent experiments, at least nine mice
were used for each genotype. (E) EpCAM1 expression for each cell subset in wild type, RANK-Tg and Traf6DTEC mice were analyzed by flow
cytometry on histograms. MFI values for EpCAM1 expression levels on the different TEC subsets (P1–P9) from RANKL-Tg mice were determined by
flow cytometry. Levels of expression were determined as N (no expression), Low, Int (intermediate) and Hi (high) expression.
doi:10.1371/journal.pone.0086129.g006
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and B). The opposite was true in 6-week-old RANKL-Tg mice in
that all populations except the P8 and P9 subsets were increased
compared to 1-week old animals (Figure 8A and B), suggesting that
RANKL-RANK signaling may be differentially required at
different stages of postnatal thymus development. Interestingly,
there was a pronounced enrichment of the P7 subset in 1-week-old
wild type and RANKL-Tg animals representing Aire+ mTECs (as
defined in Figures 3E and 4 above) (Figure 7 and 8 A and B),
suggesting that different TEC subsets are differentially abundant at
different stages of postnatal thymus development. The increase in
the P7 subset (Aire+ mTECs) in 1-week-old wild type and
RANKL-Tg mice was corroborated by an increase in the presence
of UEA-1+Aire+ mTECs in thymic sections of 1- vs. 6-week-old
mice (Figure 7 and 8 C). Collectively, these results suggest the
existence of temporal regulation of TEC subsets in the postnatal
thymus. The P2 and P3 populations could serve as progenitors
whose expansion is necessary to accommodate the expanding
neonatal thymus and facilitate the production of Aire+ mTECs for
the purpose of tolerizing the emerging T cell repertoire. Consistent
with this, it was previously shown that Aire was essential during a
perinatal window to induce long-lasting T cell tolerance and
prevent multiorgan autoimmunity [38].
Immature TEC Precursors are Present in the Adult
Thymus
To further corroborate our results described above, we also
performed 4-color immunohistochemistry on thymic sections.
Consistent with the results that RANKL overexpression led to
expansion of mTECs, we found increased staining with MHCII,
UEA-1 and Aire in the thymi of RANKL-Tg mice compared to
wild type controls (Figure S4A and B, bottom two panels and data
not shown). Expression of K5 and K8 was present throughout the
thymic sections and there was no demarcation between the
cortical and medullary compartments (Figure S4B). The fact that
all of the K5+ cells in RANKL-Tg thymi were also K8+ supports
our observations that K8 expression is widely expressed in mTEC
subsets. Moreover, as we found no or very few cortical (K8+K52)
cells in thymic sections from RANKL-Tg mice (Figure S4B and
Figure 5A), our results suggest that medullary expansion in
RANKL-Tg mice occurs at the expense of the cortex.
In contrast to RANKL-Tg mice, staining of thymic sections
from Traf6DTEC mice revealed a medulla devoid of UEA-
1hiMHCIIhi mature mTECs (P7 subset) consistent with the
marked inhibition of this population in the knockout mice (Figure
S4C, bottom two panels and Figure 5E). TEC subsets coexpressing
K5 and K8 were still evident within the medulla and corticome-
dullary junction (CMJ) of Traf6DTEC mice (Figure S4C, top
panel, solid and dashed arrows respectively) whereas K8+ cells
were present in the thymic cortex of these mice (Figure S4C, 1st
and 3rd panels). The K8+K5+ subsets within the medulla but not
the CMJ also bound low levels of UEA-1 (Figure S4C, 2nd, 3rd and
bottom panels), and expressed low levels of MHCII (Figure S4C,
second panel from bottom). The K8+K5+UEA-1low cells present in
the medulla of Traf6DTEC mice may represent the P4 and P5
(K8lowK5lowUEA-1lowMHCII2 and K8lowK5lowUEA-1low-
MHCIIlow respectively) mTEC subsets (Figure 3E), which were
still present in the thymus of these mice albeit at reduced numbers
than in wild type animals (Figure 5E). The presence of the P4 and
P5 TEC populations in the thymi of Traf6DTEC mice suggests
that in addition to Traf6 other factors may also regulate the
development of these mTEC subsets whereas Traf6 is absolutely
required for the production of the P6 and P7 populations. In
addition to K8+K5+UEA-1+ cells present in the thymic medulla of
Traf6DTEC mice, K8+K5+UEA-12 cells were also evident in
thymic CMJ of these animals (Figure S4C, dashed arrows) as well
as the CMJ of wild type mice (Figure S5). We believe that these
cells are the previously characterized minor cortical K8+K5+ CMJ
cells mentioned above represented by the P8 subset (Figure S4C,
bottom two panels). Thus, the immunohistological and flow
cytometry data presented recapitulate known aspects of TEC
development and further delineate the profiles of additional novel
TEC subsets.
RANKL-mediated Medullary Expansion Inhibits T Cell
Development
We finally examined the effect of the expansion and reduction
of the thymic medulla in RANKL-Tg and Traf6DTEC mice
respectively on T cell development. This process was apparently
normal in Traf6DTEC mice as similar percentages and total
numbers of CD4+CD8+ double positive (DP) and CD4+ and CD8+
single positive (SP) cells were present in the thymi, as well as in the
spleen and lymph nodes of these animals [29]. However,
consistent with the role of mTECs in the elimination of
autoreactive T cells, these animals developed peripheral organ-
restricted autoimmunity primarily affecting their liver [29]. In
contrast, RANKL overexpression led to a marked expansion of the
medulla 6 weeks after birth and was further exacerbated at 3
months of age (Figure 9A and B). This medullary expansion in
RANKL-Tg animals correlated with altered thymocyte develop-
ment evident as decreased percentages of CD4+CD8+ double
positive (DP), increased percentages of CD4+, CD8+ thymocytes,
and skewed CD4:CD8 cell ratios towards the CD8 lineage
(Figure 9C and D and data not shown). Despite the increased
frequency of the different thymocyte populations, the total
numbers of all thymocyte subsets were markedly reduced in
RANKL-Tg mice compared to control animals (Figure 9E).
The decrease in DP thymocytes in RANKL-Tg mice was
accompanied by a concomitant increase in the frequency of
CD42CD82 double negative (DN) cells compared to control mice
(Figure 9C and D right dot plots and data not shown). Staining of
thymic cell suspensions with anti-CD25 and -CD44 antibodies
revealed significant increases in the total numbers of the DN1
(CD44+CD252) thymocyte population in RANKL-Tg mice
compared to controls suggestive of a block in T cell development
(Figure 9C, D and F). This increase was not due to the presence of
non-T cell lineage cells as exclusion of B cells, monocytes/
macrophages and NKT1.1 with specific antibodies had no effect
on the DN1 population of RANKL-Tg mice (data not shown).
The increase in the DN1 population associated with a marked
reduction in the total cell numbers of thymocytes in DN2–DN4
differentiation stages in 6-week and 3-month-old RANKL-Tg
mice compared to wild type controls (Figure 9C, D and F). The
block in thymocyte development and reduction in total thymocyte
numbers associated with peripheral lymphopenia, as the numbers
of T cells in the spleen and lymph nodes of RANKL transgenic
animals were drastically reduced compared to controls (data not
shown). These results suggest that medullary expansion and
reduced cortical area due to RANKL overexpression in thymo-
cytes leads to a block in thymocyte development. We believe the
lack of sufficient cortical mass may be the cause of defective
thymocyte development as antigen presentation by cTECs in the
cortex is required for survival, expansion and positive selection of
thymocytes [3,39,40].
Discussion
Existing evidence suggests that Aire upregulation correlates with
a rapid turnover of mature TECs, suggesting that there is
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Figure 7. Different TEC subsets are temporally regulated during postnatal thymus development in wild type mice. (A) UEA/
MHCIIRK8/K5 (blue dots) and K8/K5RUEA/MHCII (red dots) overlays were generated as in Figure 2A and B comparing patterns of UEA-1, MHCII, K8
and K5 expression in 1-week-old vs. 6-week-old wild type mice as shown. (B) Quantification of the total numbers of TEC subpopulations in 1-week old
and 6-week-old wild type mice within the total gated populations was performed by flow cytometry. Bar graphs represent mean+SEM with n = 9 from
three independent experiments. (C) Frozen thymic sections from 1- and 6-week-old wild type were stained with anti-Aire FITC and rhodamine-
conjugated UEA-1 and analyzed by fluorescence microscopy. Scale bar = 100 mm.
doi:10.1371/journal.pone.0086129.g007
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continued replenishment of this cellular compartment from a pool
of progenitor cells in the thymus [41]. Despite this evidence, it is
unclear whether the CD80/86lowMHCIIlow cell subset exclusively
gives rise to mature CD80/86hiMHCIIhiAire+ mTECs or whether
other unidentified mTEC progenitors exist [42,43]. Because the
thymic medulla exhibited cellular heterogeneity, in this report we
Figure 8. RANKL differentially regulates TEC expansion in the post-natal vs. mature thymus. (A) UEA/MHCIIRK8/K5 (blue dots) and K8/
K5RUEA/MHCII (red dots) overlays generated as in Figure 2A and B comparing patterns of UEA-1, MHCII, K8 and K5 expression in 1- vs. 6-week-old
RANKL-Tg mice. (B) Quantification of the total numbers of TEC subpopulations in 1- and 6-week-old RANKL-Tg type mice was performed by flow
cytometry. Bar graphs represent mean+SEM with n = 9 from three independent experiments. (C) Frozen thymic sections from 1- and 6-week-old
RANKL-Tg mice were stained with anti-Aire FITC and rhodamine-conjugated UEA-1 and analyzed by fluorescence microscopy. Scale bar = 100 mm.
doi:10.1371/journal.pone.0086129.g008
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Figure 9. RANKL-mediated medullary expansion inhibits T cell development. (A and B) Mosaic images of H&E stained thymic sections of
6-week and 3-month old wild type and RANKL-Tg mice showing progressive expansion of the medulla in response to RANKL expression. Scale
bar = 500 mm. Micrographs are representative of at least three independent experiments. (C–F). Thymocyte suspensions from 6-week and 3-month
old wild type and RANKL transgenic mice were stained with anti-CD4, -CD8, -CD44 and-CD25 antibodies and the total numbers of the different
thymocyte subpopulations were analyzed by flow cytometry. Bar graphs represent the mean+SEM. n=9 for each genotype, results were pooled from
at least three independent experiments. DP= double positive; DN1-4= double negative stages 1–4.
doi:10.1371/journal.pone.0086129.g009
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Figure 10. Model of thymic epithelial cell development. Production of TEC subsets is temporally regulated in the adult vs. the neonatal
thymus. In the adult thymus the P2 cell pool contains cells expressing low levels of K5 which may serve as precursors to both the P3 and P8
populations. Expression of the UEA-1 receptor in the P3 population commits the cells into the mTEC lineage. The P8 population could serve as a
bipotent precursor by upregulating the UEA-1 receptor and contributing to the formation of the P5 subset or by driving the cells into the cTEC
lineage through an intermediate P9 population that involves K5 downregulation (as it occurs in the most mature mTECs) and upregulation of MHCII
and EpCAM1. The large expansion of the P5 population compared to the P4 subset may represent a checkpoint during TEC differentiation after which
P5 cells give rise to mature P7 mTECs either directly or indirectly through the P6 subset. Alternatively the P6 subset may represent terminally
differentiated post Aire-stage mTEC expressing low levels of MHCII. In the neonatal thymus, the expanded P2 and P3 cell subsets could give rise to
the mature P7 population through the same pathway as the adult thymus or directly to promote rapid production of Aire+ mTECs (P7) to tolerize the
emerging T cell repertoire. Whereas RANKL does not directly regulate the production of CMJ cTECs, Traf6 regulates generation of mTECs either
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assessed keratin expression in relation to other epithelial markers
to identify novel TEC populations. A total of nine populations
were identified which were classified as mTECs and minor cTECs
based on UEA-1 binding and/or expression of the cortical marker
LY51 and K8/K5. The earliest detectible expression of any of the
markers tested was that of K5 in the P2 subset followed by low
levels of UEA-1 binding in the P3 population. Contrary to the
notion that K8 is a cTEC marker, K8 expression was first
expressed in the UEA-1+ P4 subpopulation, and steadily increased
in the P5–P7 cell subsets with the highest expression levels evident
in the P7 population. Upregulation of MHCII expression occurred
in the P5 subset which represents the previously characterized
TEClow (UEA-1lowCD80lowMHCIIlow) population [17,33]. In
addition, we found another MHCIIlow population binding high
levels of UEA-1 (P6) that we believe represents an intermediate
novel population between the TEClow (P5) and TEChi (P7) mTEC
subsets. However, the possibility that these cells represent the
involucrin+ end-stage maturation mTECs characterized by loss of
Aire expression and downregulation of CD80 and MHCII cannot
be excluded [35,44,45]. K8 expression was highest and coincided
with upregulation of Aire expression in the P7 subset representing
the previously characterized TEChi population [17,33], whereas
K5 expression was downregulated to intermediate levels in the
same cells. Whether K5 downregulation in the most mature Aire+
mTECs is of functional significance is currently unclear. Together,
these results suggest that K8 and K5 expression is not solely
confined in the thymic cortex or medulla respectively but rather
expression of these proteins together with MHCII upregulation
and UEA-1 binding is dynamically regulated in different mTEC
and cTEC subsets. The different populations may represent
different stages of TEC differentiation where the P2 subset
expressing low levels of K5 may be representative of an early stage
along the mTEC lineage differentiation followed by cells in stages
P3–P4 whereas the P5 and P7 subsets represent the known TEClow
and TEChi mTECs respectively.
As CD80/86 and MHCII upregulation was previously linked to
mTEC maturation [33,41], the progressive upregulation of
cortical, medullary and epithelial markers observed within the
P2–P9 cell subsets, could be indicative of a precursor-product
relationship between the different populations. Support for such
precursor-product relationship was provided by the experiments
using the RANKL-Tg and Traf6DTEC mice. RANKL expression
significantly increased while Traf6 deletion reduced the total
numbers of the TEC subsets particularly cells within the
CD452EpCAM1+ subsets (P2–P7). The low numbers of Ep-
CAM1+ cells within the P2–P4 populations corroborate the
existence of a small number of precursor cells that may give rise to
increasingly larger numbers of progeny as they proceed to
maturity. Support for the idea that the P2–P3 TEC subsets may
act as mTEC precursors was also provided by the observation that
these populations were enriched in the thymus of 1- vs. 6-week-old
wild type mice and that these populations contained EpCAM1+
cells that responded to RANK stimulation in RANKL-Tg mice
and in in vitro cultures. It is possible that enrichment of these
populations in the young thymus is required for the accompanying
increased production of mature cells coinciding with the window
of Aire-mediated tolerance of the emerging T cell repertoire [38].
Our attempts to directly show that the P2–P3 subpopulations act
as precursors to more mature lineages expressing MHCII, while
showing the existence of RANK-responsive cells within these
populations, failed to produce MHCII+ TECs suggesting that
other events may be required for progression of these cells to more
mature lineages. Our efforts were also hindered by the phenotypic
overlap of these cell subsets which prevented sorting of individual
populations. Therefore, future in vivo experiments with sorted
populations using additional surface markers will be required to
definitively establish a precursor product relationship between the
different populations we identified.
K8+K5+ cells at the CMJ of the thymus were previously
postulated to be TEC precursors and were designated as minor
cortical cells based on their lack of binding UEA-1 [24,46,47]. We
also identified two cell subsets by flow cytometry, P8 and P9 which
coexpressed different levels of K8, K5 and MHCII and in the case
of P9 high levels of LY51, but bound no UEA-1. K8+K5+UEA-
12MHCIIlow cells were also shown by immunohistochemistry to
occupy the CMJ of the thymus of wild type mice which we believe
represent the previously described minor cortical cells. Currently,
we cannot exclude the possibility that the K8+K5+ cells detected
by immunohistochemistry in the CMJ are a mix of both the P8
and P9 populations, as it is difficult to ascertain the precise
expression levels of proteins by immunostaining. Interestingly,
both RANKL overexpression and deletion of Traf6 in TECs
significantly inhibited the P8 and P9 cell subsets. The reduction in
the P8 and P9 populations in the case of RANKL overexpression
could be due to active inhibition of differentiation of these cells by
RANKL, or RANKL-mediated preferential shunting of an early
precursor (P2) towards the medullary lineage. This would be
consistent with the medullary expansion evident in the thymi of
RANKL-Tg mice accompanied by a concomitant reduction of the
cortex. Similarly, Traf6 may regulate the production of the P8
subset from an EpCAM1+ precursor within the P2 population by
selective upregulation of K8 expression. The coexpression and up/
down regulation of cortical and medullary markers on the different
TEC subsets is consistent with recent evidence showing that the
cortical marker b5t is expressed at some point during mTEC
development and that progenitors expressing CD205 (a cortical
marker) give rise to both cTECs and mTECs [32,48]. Differential
expression of surface markers at different stages of postnatal
thymus development could also correlate with temporal regula-
tion/expansion of different set subsets in wild type mice. A
working model of TEC differentiation based on our findings is
schematically presented in Figure 10.
Finally, expansion of the thymic medulla as a result of RANKL
expression had a negative impact on T cell development
manifested as an early developmental block in thymocyte
development. This developmental block associated with reduced
total numbers of DP and mature CD4+ and CD8+ SP thymocytes
and peripheral lymphopenia (unpublished results). Our results
overall have important implications in human disease conditions
because genetic defects that impair proper TEC development or
function, as well as disruption of TEC-thymocyte crosstalk have
deleterious effects on thymic function. For example, patients with
benign medullary epithelial thymomas experience deregulation of
lymphocyte positive and negative selection leading to abnormal
thymocyte development and proliferation, autoimmunity, and/or
immunodeficiency [49,50]. Therefore, improved understanding of
TEC development and the molecular events that regulate their
differentiation can lead to therapeutic interventions for managing
and/or treating autoimmune diseases and immune deficiencies as
directly or indirectly through CMJ cTECs. Because Traf6 deletion does not interfere with cortex development, other mechanisms contribute to mature
cTEC production.
doi:10.1371/journal.pone.0086129.g010
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well as thymopoiesis during hematopoietic stem cell transplanta-
tion.
Supporting Information
Figure S1 Different TEC subsets express variable levels
of medullary and cortical markers determined by MFI
values. (A) The percentages of as EpCAM1+ cells within the total
CD452 cells gated were quantified by flow cytometry. (B–F)
Expression levels of each marker on the different cells subsets (P1–
P9) was based on mean fluorescence intensity (MFI) values
determined by flow cytometry and were assigned to one of four
levels of expression as described in Figure 6. Bar graphs represent
the mean+SEM. n= 16, results were pooled from at least three
independent experiments.
(TIF)
Figure S2 The P9 cell subset contains cTECs expressing
high levels of the cortical marker LY51. (A) TEC cell
suspensions from 6 week old mice were stained with anti-CD45, -
LY51, -EpCAM1 and -MHCII antibodies and UEA-1 and stained
cells were analyzed by flow cytometry on a dot plot. cTECs and
mTECs ate shown within gates 1 and 2 respectively where gate 3
represents LY51lowEpCAM1low cells. (B) MFI values of EpCAM1
and Ly51 expression were determined by flow cytometry and
levels of expression were assigned as shown. (C) The different cell
populations (1–3) subgated on LY51/EpCAM1 dot plots from (A)
were overlaid onto UEA-1/MHCII dot plots to identify cells
coexpressing these markers. LY51 marker expression levels within
gates 1–7 were analyzed by flow cytometry on histograms. Bar
graphs represent the mean+SEM. n=3, results shown were
representative of three independent experiments.
(TIF)
Figure S3 In vitro stimulation of P1–P4 cells with anti-
RANKL antibody leads to expansion of EpCAM+ TECs.
(A) TEC suspensions were stained with anti-CD45, -MHCII and
UEA-1 and cells were sorted based on negative and low UEA-1
binding and negative MHCII expression as shown (rectangle). Six
3-week old mice were pooled together for sorting. (B) Sorted cells
were incubated in vitro with anti-RANK antibody and the
percentage of EpCAM1+ and MHCII+ thymic epithelial cells
were quantified after 3 days in culture by flow cytometry. (C)
Expression of EpCAM1 and MHCII on shorted TECs treated
with anti-RANK antibody or left untreated for three days in vitro
were analyzed on histograms. Bar graphs represent the mean+-
SEM. n= 3, results were pooled from three independent
experiments *p,0.05.
(TIF)
Figure S4 Immature TECs are present in the thymus of
Traf6DTEC animals. (A–C) Frozen thymic sections from ,6–
8-week old wild type, RANKL-Tg and Traf6DTEC were stained
with anti-K5, -K8 and -MHCII antibodies and rhodamine-
conjugated UEA-1 and analyzed by fluorescence microscopy.
K8lowK5lowUEA-1lowMHCIIlow mTECs (solid arrows) and K8low-
K5lowUEA-12MHCIIlow minor cTECs (dotted arrows) are present
in the thymus of Traf6DTEC cKO mice whereas the medulla is
devoid of UEAhiMHCIIhi mature mTECs. Micrographs shown
are representative of at least three separate experiments. Scale
bar = 100 mm.
(TIF)
Figure S5 The P8 population is present in the CMJ of
the wild type thymus. Frozen thymic sections from,6–8-week
old wild type mice were stained with anti-K5, -K8, -MHCII
antibodies and UEA-1 and analyzed by fluorescence microscopy.
Solid and dashed lines demarcate the cortico-medullary junction
(CMJ) of the thymus. Arrowheads point to cells that do not bind
UEA-1 but express low levels of K5, K8 and MHCII likely
representing the P8 population characterized by flow cytometry in
Figure 2. Scale bar = 50 mm.
(TIF)
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